GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials

Publication
Endocrine
Shu-Ting YANG
Shu-Ting YANG
Physician

An endocrinologist passionate about artificial intelligence and diabetes, focusing on applying machine learning and bioinformatics to diabetes heterogeneity research.